I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Krens, Stefanie D
26
results:
Search for persons
X
Format
Online (26)
Mediatypes
Articles (Online) (9)
OpenAccess-fulltext (17)
Sorted by: Relevance
Sorted by: Year
?
1
Exposure–response analyses of cabozantinib in patients with..:
Krens, Stefanie D.
;
van Erp, Nielka P.
;
Groenland, Stefanie L.
...
BMC Cancer. 22 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1186/..
?
2
Excessive toxicity of cabozantinib in a phase II study in p..:
van Boxtel, Wim
;
Uijen, Maike J.M.
;
Krens, Stefanie D.
...
European Journal of Cancer. 161 (2022) - p. 128-137 , 2022
Link:
https://doi.org/10.1016/..
?
3
The impact of a 1‐hour time interval between pazopanib and ..:
Krens, Stefanie D.
;
Lubberman, Floor J. E.
;
van Egmond, Marthe
...
International Journal of Cancer. 148 (2021) 11 - p. 2799-2806 , 2021
Link:
https://doi.org/10.1002/..
?
4
Lost in third space: altered tyrosine-kinase inhibitor phar..:
Krens, Stefanie D.
;
Mulder, Sasja F.
;
van Erp, Nielka P.
Cancer Chemotherapy and Pharmacology. 89 (2021) 2 - p. 271-274 , 2021
Link:
https://doi.org/10.1007/..
?
5
Exposure‐toxicity relationship of cabozantinib in patients ..:
Krens, Stefanie D.
;
van Boxtel, Wim
;
Uijen, Maike J. M.
...
International Journal of Cancer. 150 (2021) 2 - p. 308-316 , 2021
Link:
https://doi.org/10.1002/..
?
6
The relationship between sunitinib exposure and both effica..:
Westerdijk, Kim
;
Krens, Stefanie D.
;
van der Graaf, Winette T.A.
...
British Journal of Clinical Pharmacology. 87 (2020) 2 - p. 326-335 , 2020
Link:
https://doi.org/10.1111/..
?
7
Quantification of cobimetinib, cabozantinib, dabrafenib, ni..:
Krens, Stefanie D.
;
van der Meulen, Eric
;
Jansman, Frank G.A.
..
Biomedical Chromatography. 34 (2020) 3 - p. , 2020
Link:
https://doi.org/10.1002/..
?
8
Unexpected Serotonin Syndrome, Epileptic Seizures, and Cere..:
Spoelder, Antoinette S.
;
Louwerens, Jan K. G.
;
Krens, Stefanie D.
...
Journal of Forensic Sciences. 64 (2019) 6 - p. 1950-1952 , 2019
Link:
https://doi.org/10.1111/..
?
9
Excessive toxicity of cabozantinib in a phase II study in p..:
van Boxtel, Wim
;
Uijen, Maike J M
;
Krens, Stefanie D
...
https://research.rug.nl/en/publications/aca21af0-1a77-4883-bf4d-0ff7503e61bc. , 2022
Link:
https://hdl.handle.net/1..
?
10
Exposure-toxicity relationship of cabozantinib in patients ..:
Krens, Stefanie D
;
van Boxtel, Wim
;
Uijen, Maike J. M
...
https://research.rug.nl/en/publications/295c939b-d2d6-4480-8547-551539a0230d. , 2022
Link:
https://hdl.handle.net/1..
?
11
Exposure–response analyses of cabozantinib in patients with..:
Krens, Stefanie D
;
van Erp, Nielka P
;
Groenland, Stefanie L
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892746/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
12
The impact of a 1-hour time interval between pazopanib and ..:
Krens, Stefanie D
;
Lubberman, Floor J. E
;
van Egmond, Marthe
...
https://research.rug.nl/en/publications/e42dfa52-d7d6-4050-9be3-7a97b630aa4b. , 2021
Link:
https://hdl.handle.net/1..
?
13
The impact of a 1‐hour time interval between pazopanib and ..:
Krens, Stefanie D
;
Lubberman, Floor J. E
;
van Egmond, Marthe
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048885/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
14
Exposure‐toxicity relationship of cabozantinib in patients ..:
Krens, Stefanie D
;
van Boxtel, Wim
;
Uijen, Maike J. M
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291492/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
15
Quantification of cobimetinib, cabozantinib, dabrafenib, ni..:
Krens, Stefanie D
;
van der Meulen, Eric
;
Jansman, Frank G A
..
https://research.rug.nl/en/publications/5057cf78-cf15-401b-9f6e-1596a1912bd8. , 2020
Link:
https://hdl.handle.net/1..
1-15